Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-16 9:35 pm Purchase | 2024-09-12 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,742,993 19.990% | 149,598 (+1.41%) | Filing History |
| 2024-08-09 4:09 pm Sale | 2024-07-31 | 13D | Janux Therapeutics, Inc. JANX | ORBIMED ADVISORS LLC | 1,965,266 3.800% | -684,198 (-25.82%) | Filing History |
| 2024-06-05 7:28 pm Sale | 2024-06-03 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 7,304,490 14.100% | -1,496,249 (-17.00%) | Filing History |
| 2024-03-06 6:54 pm Purchase | 2024-03-04 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,593,395 19.990% | 1,922,751 (+22.18%) | Filing History |
| 2024-03-04 8:07 pm Sale | 2024-02-29 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 8,800,739 17.100% | -965,615 (-9.89%) | Filing History |
| 2024-02-14 5:53 pm Sale | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | EcoR1 Capital, LLC | 0 0.000% | -3,255,270 (Position Closed) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | Citadel Advisors LLC | 3,125,897 6.800% | 999,762 (+47.02%) | Filing History |
| 2024-02-14 09:43 am Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.900% | 472,873 (+11.51%) | Filing History |
| 2024-02-09 4:31 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | Campbell David Alan | 2,545,075 5.300% | 165,140 (+6.94%) | Filing History |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 4,671,213 10.117% | -934,647 (-16.67%) | Filing History |
| 2024-02-01 4:15 pm Purchase | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | Bregua Corp | 3,830,257 8.300% | 81,007 (+2.16%) | Filing History |
| 2023-11-15 6:22 pm Purchase | 2023-11-13 | 13D | Janux Therapeutics, Inc. JANX | Avalon Ventures XI L.P. | 9,766,354 21.200% | 869,645 (+9.77%) | Filing History |
| 2023-07-10 4:01 pm Purchase | 2023-06-29 | 13G | Janux Therapeutics, Inc. JANX | Citadel Advisors LLC | 2,126,135 5.100% | 2,126,135 (New Position) | Filing History |
| 2023-05-30 4:45 pm Purchase | 2023-05-17 | 13G | Janux Therapeutics, Inc. JANX | BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.800% | 4,106,945 (New Position) | Filing History |
| 2023-02-10 4:32 pm Purchase | 2022-12-31 | 13G | Janux Therapeutics, Inc. JANX | Campbell David Alan | 2,379,935 5.400% | 103,323 (+4.54%) | Filing History |
| 2023-02-09 11:40 am Sale | 2022-12-31 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 1,837,791 4.400% | -563,102 (-23.45%) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Janux Therapeutics, Inc. JANX | FMR LLC | 5,605,860 13.455% | 614,458 (+12.31%) | Filing History |
| 2023-01-20 5:32 pm Purchase | 2023-01-10 | 13G | Janux Therapeutics, Inc. JANX | EcoR1 Capital, LLC | 3,255,270 7.800% | 3,255,270 (New Position) | Filing History |
| 2022-02-11 6:30 pm Purchase | 2021-12-31 | 13G | Janux Therapeutics, Inc. JANX | JANUS HENDERSON GROUP PLC JHG | 2,400,893 5.800% | 2,400,893 (New Position) | Filing History |
| 2022-02-11 4:01 pm Purchase | 2021-12-31 | 13G | Janux Therapeutics, Inc. JANX | Campbell David Alan | 2,276,612 5.500% | 2,276,612 (New Position) | Filing History |